Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells.
Cancer develops following the accumulation of genetic and epigenetic alterations that inactivate tumor suppressor genes and activate proto-oncogenes. Dysregulated cyclin-dependent kinase (CDK) activity has oncogenic potential in breast cancer due to its ability to inactivate key tumor suppressor net...
Guardado en:
Autores principales: | Damian J Junk, Rocky Cipriano, Martha Stampfer, Mark W Jackson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/51ef4326946446ef88121451b27864fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
por: Jean-Philippe Coppé, et al.
Publicado: (2008) -
Impacto do oncogene C-MYC no câncer
por: Mário Henrique Girão Faria, et al.
Publicado: (2006) -
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance
por: Yong-Li Dong, et al.
Publicado: (2021) -
ZNF768 links oncogenic RAS to cellular senescence
por: Romain Villot, et al.
Publicado: (2021) -
Intercellular transfer of oncogenic H-Ras at the immunological synapse.
por: Oded Rechavi, et al.
Publicado: (2007)